This inventor holds 1 USPTO granted patent. Top assignee: Peptron, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jae Pyoung Cho: Inventor in Pharmaceutical Formulation
Introduction
Jae Pyoung Cho is an inventor associated with Peptron, Inc. His patent work concerns a sustained-release formulation involving semaglutide, a pharmaceutical compound.
Latest Patents
Cho is listed as an inventor on 1 patent: “Sustained Release Formulation Composition Comprising Semaglutide or Pharmaceutically Acceptable Salt Thereof.” The patent describes a formulation designed to release semaglutide or its pharmaceutically acceptable salt over an extended period.
Career Highlights
Cho’s recorded patent activity is connected to pharmaceutical formulation research at Peptron, Inc. The available information identifies his contribution through the semaglutide sustained-release patent.
Collaborations
Cho is listed alongside fellow inventors Seung Gu Chang and Ji Hyang Lee on the patent. Their shared work reflects a collaborative effort in developing the formulation.
Conclusion
Jae Pyoung Cho’s patent record highlights his involvement in pharmaceutical innovation through a sustained-release semaglutide formulation developed with collaborators at Peptron, Inc.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile